Open-heart surgery in patients with liver cirrhosis: Indications, risk factors, and clinical outcomes

European Surgical Research

Volumn 39, Issue 2, 2007, Pages 67-74

  An, Y ^a   Xiao, Y B ^a   Zhong, Q J ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiopulmonary bypass; Child Pugh classification, liver cirrhosis; Liver cirrhosis, open heart surgery; Open heart surgery, liver cirrhosis; Postoperative complications mortality, open heart surgery

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; GASTROINTESTINAL DISEASE; HEART FAILURE; HEART TAMPONADE; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; MALE; MITRAL VALVE REPLACEMENT; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPEN HEART SURGERY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK FACTOR; SEPSIS; SEX RATIO; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TRICUSPID VALVE;

ADULT; AGED; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MORBIDITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 34047131273     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099145     Document Type: Article

References (31)

1. McCaughan GW: Asian perspectives on viral hepatitis: hepatitis C virus infection. J Gastroenterol Hepatol 2000;15(suppl):G90-G93.
2. Hirata N, Sawa Y, Matsuda H: Predictive value of preoperative serum cholinesterase concentration in patients with liver dysfunction undergoing cardiac surgery. J Card Surg 1999;14:172-177.
3. Hayashida N, Shoujima T, Teshima H, Yokokura Y, Takagi K, Tomoeda H, Aoyagi S: Clinical outcome after cardiac operations in patients with cirrhosis. Ann Thorac Surg 2004;77:500-505.
4. Kaplan M, Cimen S, Kut MS, Demirtas MM: Cardiac operations for patients with chronic liver disease. Heart Surg Forum 2002;5:60-65.
5. Yamamoto T, Takazawa K, Hariya A, Ishikawa N, Dohi S, Matsushita S: Off-pump coronary artery bypass grafting in a patient with liver cirrhosis. Jpn J Thorac Cardiovasc Surg 2002;50:526-529.
6. Ninomiya M, Takamoto S, Kotsuka Y, Ohtsuka T: Indication and perioperative management for cardiac surgery in patients with liver cirrhosis: our experience with 3 patients. Jpn J Thorac Cardiovasc Surg 2001;49:391-394.
7. Yaku H, Fermanis GG, Horton DA: Open heart surgery in a patient with liver cirrhosis and thrombocytopenia. Aust N Z J Surg 2000;70:77-78.
8. Bizouarn P, Ausseur A, Desseigne P, Le Teurnier Y, Nougarede B, Train M, Michaud JL: Early and late outcome after elective cardiac surgery in patients with cirrhosis. Ann Thorac Surg 1999;67:1334-1338.
9. Klemperer JD, Ko W, Krieger KH, Connolly M, Rosengart TK, Altorki NK, Lang S, Isom OW: Cardiac operations in patients with cirrhosis. Ann Thorac Surg 1998;65:85-87.
10. Ota T, Okamura S: Perioperative management in patients with liver cirrhosis undergoing open heart surgery. Kyobu Geka 1996;49:916-920.
11. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transsection of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-649.
12. Biancari F, Kangasniemi OP, Luukkonen J, Vuorisalo S, Satta J, Pokela R, Juvonen T: EuroSCORE predicts immediate and late outcome after coronary artery bypass surgery. Ann Thorac Surg 2006;82:57-61.
13. Aggarwal A, Ong P, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC: Predictors of mortality and resource utilization in cirrhotic patients admitted to the intensive care unit. Chest 2001;119:1489-1497.
14. Doberneck RC, Sterling WA, Allison DC: Morbidity and mortality after operation in nonbleeding cirrhotic patients. Am J Surg 1983;146:306-309.
15. Kay JH: Surgical treatment of tricuspid regurgitation. Ann Thorac Surg 1992;53:1132-1133.
16. Toyoda Y, Okada M, Sugimoto T, Yoshida M, Ataka K, Yamashita C: Successful surgical treatment of cardiac cirrhosis: tricuspid surgery and plasma exchange. J Cardiovasc Surg (Torino) 1996;37:305-307.
17. Paparella D, Yau TM, Young E: Cardiopulmonary bypass induced inflammation: pathophysiology and treament. An update. Eur J Cardiothorac Surg 2002;21:232-244.
18. Okano N, Miyoshi S, Owada R: Impairment of hepatosplanchnic oxygenation and increase of serum hyaluronate during normothermic and mild hypothermic cardiopulmonary bypass. Anesth Analg 2002;95:278-286.
19. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D: Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 2000;140:111-120.
20. Michalopoulos A, Alivizatos P, Geroulanos S: Hepatic dysfunction following cardiac surgery: determinants and consequences. Hepatogastroenterology 1997;44:779-783.
21. Morris JJ, Hellman CL, Gawey BJ, Ramsay MA, Valek TR, Gunning TC, Swygert TH, Shore-Lesserson L, Lalehzarian F, Brayman KL, et al: Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cardiothorac Vasc Anesth 1995;9:322-332.
22. Hill DM, Warren SE, Mitas JA: Hepatic coma after open heart surgery. South Med J 1980;73:906-911.
23. Matsuda H, Takano H, Nakano S, et al: Analysis of acute and chronic heart failure in view of hepatic oxygen supply-demand relationship using hepatic venous oxygen saturation. Jpn Circ J 1989;53:175-179.
24. Nollert G, Sperling J, Sakamoto T, Jaeger BR, Jonas RA: Higher hematocrit improves liver blood flow and metabolism during cardiopulmonary bypass in piglets. Thorac Cardiovasc Surg 2001;49:226-230.
25. Mathie RT: Hepatic blood flow during cardiopulmonary bypass. Crit Care Med 1993;21(suppl 2):72-76.
26. Collins JD, Bassendine MF, Ferner R, Blesovsky A, Murray A, Pearson DT, James OF: Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet 1983;1:1119-1125.
27. Chu CM, Chang CH, Liaw YF, Hsieh MJ: Jaundice after open-heart surgery. Thorax 1984;39:52-56.
28. Reinhartz O, Farrar DJ, Hershon JH, Avery GJ Jr, Haeusslein EA, Hill JD: Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg 1998;116:633-640.
29. Watanabe Y, Kumon K: Assessment by pulse dye-densitometry indocyanine green (ICG) clearance test of hepatic function of patients before cardiac surgery: its value as a predictor of serious postoperative liver dysfunction. J Cardiothorac Vasc Anesth 1999;13:299-303.
30. Nilsson J, Algotsson L, Hoglund P, Luhrs C, Brandt J: EuroSCORE predicts intensive care unit stay and costs of open heart surgery. Ann Thorac Surg 2004;78:1528-1534.
31. Vanagas G, Kinduris S, Buivydaite K: Assessment of validity for EuroSCORE risk stratification system. Scand Cardiovasc J 2005;39:67-70.